Literature DB >> 23175712

Women "jurors" are asked how to present risk-benefit ratio of breast cancer screening.

Nigel Hawkes.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23175712     DOI： 10.1136/bmj.e7886

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.

Authors:  Lucie Rychetnik; Jenny Doust; Rae Thomas; Robert Gardiner; Geraldine Mackenzie; Paul Glasziou
Journal:  BMJ Open       Date:  2014-04-30       Impact factor: 2.692

2.  Women's participation in breast cancer screening in France--an ethical approach.

Authors:  Grégoire Moutel; Nathalie Duchange; Sylviane Darquy; Sandrine de Montgolfier; Frédérique Papin-Lefebvre; Odile Jullian; Jérôme Viguier; Hélène Sancho-Garnier
Journal:  BMC Med Ethics       Date:  2014-08-16       Impact factor: 2.652

3.  CJCheck Stage 1: development and testing of a checklist for reporting community juries - Delphi process and analysis of studies published in 1996-2015.

Authors:  Rae Thomas; Rebecca Sims; Chris Degeling; Jackie M Street; Stacy M Carter; Lucie Rychetnik; Jennifer A Whitty; Andrew Wilson; Paul Ward; Paul Glasziou
Journal:  Health Expect       Date:  2016-10-05       Impact factor: 3.377

4.  A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain.

Authors:  J Waller; K L Whitaker; K Winstanley; E Power; J Wardle
Journal:  Br J Cancer       Date:  2014-08-28       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.